Literature DB >> 20736783

Medical therapy of pericardial diseases: part I: idiopathic and infectious pericarditis.

Massimo Imazio1, Antonio Brucato, Bongani M Mayosi, Francesco Giuseppe Derosa, Chiara Lestuzzi, Antonio Macor, Rita Trinchero, David H Spodick, Yehuda Adler.   

Abstract

The treatment of pericardial diseases is largely empirical because of the relative lack of randomized trials compared with other cardiovascular diseases. The main forms of pericardial diseases that can be encountered in the clinical setting include acute and recurrent pericarditis, pericardial effusion with or without cardiac tamponade, and constrictive pericarditis. Medical treatment should be targeted at the cause of the disease as much as possible. However, the cause of pericardial diseases may be varied and depends on the prevalence of specific diseases (especially tuberculosis). The search for an etiology is often inconclusive, and most cases are classified as idiopathic in developed countries where tuberculosis is relatively rare, whereas a tuberculous etiology is often presumed in developing countries where tuberculosis is endemic. The aim of the present article is to review current medical therapy for pericardial diseases, highlighting recent significant advances in clinical research, ongoing challenges and unmet needs. Following a probabilistic approach, the most common causes are considered (idiopathic, viral, tuberculous, purulent, connective tissue diseases and neoplastic pericardial disease). In this article, the therapy of idiopathic and more common forms of infectious pericarditis (viral and bacterial) is reviewed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20736783     DOI: 10.2459/JCM.0b013e3283340b97

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  14 in total

Review 1.  Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis.

Authors:  Massimo Imazio; Yehuda Adler
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

Review 2.  Pyopericardium followed by constrictive pericarditis due to Corynebacterium diphtheriae.

Authors:  Athanassios Krassas; Timothy Sakellaridis; Michalis Argyriou; Christos Charitos
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-08

Review 3.  New clinical trials in acute and recurrent pericarditis.

Authors:  Massimo Imazio
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

4.  Pericarditis and pericardial effusion: management update.

Authors:  Dina M Sparano; R Parker Ward
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-12

Review 5.  Diagnosis and Management of Acute Heart Failure in Sub-Saharan Africa.

Authors:  Alice Kidder Bukhman; Vizir Jean Paul Nsengimana; Mindy C Lipsitz; Patricia C Henwood; Endale Tefera; Shada A Rouhani; Damas Dukundane; Gene Y Bukhman
Journal:  Curr Cardiol Rep       Date:  2019-08-31       Impact factor: 2.931

6.  Pyopericardium progressing to tamponade in a patient with immune thrombocytopenia.

Authors:  Manoj Gopalakrishnan; Robin George Manappallil; Harilal Nambiar; John Francis John
Journal:  BMJ Case Rep       Date:  2018-05-16

Review 7.  Myocarditis.

Authors:  Sandeep Sagar; Peter P Liu; Leslie T Cooper
Journal:  Lancet       Date:  2011-12-18       Impact factor: 79.321

8.  The unmasking of a pyopericardium.

Authors:  Benjamin Robert Syer Cracknell; Dhiraj Ail
Journal:  BMJ Case Rep       Date:  2015-03-03

9.  Pericarditis: pathophysiology, diagnosis, and management.

Authors:  Massimo Imazio
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

10.  Brazilian Society of Cardiology Guideline on Myocarditis - 2022.

Authors:  Marcelo Westerlund Montera; Fabiana G Marcondes-Braga; Marcus Vinícius Simões; Lídia Ana Zytynski Moura; Fabio Fernandes; Sandrigo Mangine; Amarino Carvalho de Oliveira Júnior; Aurea Lucia Alves de Azevedo Grippa de Souza; Bárbara Maria Ianni; Carlos Eduardo Rochitte; Claudio Tinoco Mesquita; Clerio F de Azevedo Filho; Dhayn Cassi de Almeida Freitas; Dirceu Thiago Pessoa de Melo; Edimar Alcides Bocchi; Estela Suzana Kleiman Horowitz; Evandro Tinoco Mesquita; Guilherme H Oliveira; Humberto Villacorta; João Manoel Rossi Neto; João Marcos Bemfica Barbosa; José Albuquerque de Figueiredo Neto; Louise Freire Luiz; Ludhmila Abrahão Hajjar; Luis Beck-da-Silva; Luiz Antonio de Almeida Campos; Luiz Cláudio Danzmann; Marcelo Imbroise Bittencourt; Marcelo Iorio Garcia; Monica Samuel Avila; Nadine Oliveira Clausell; Nilson Araujo de Oliveira; Odilson Marcos Silvestre; Olga Ferreira de Souza; Ricardo Mourilhe-Rocha; Roberto Kalil Filho; Sadeer G Al-Kindi; Salvador Rassi; Silvia Marinho Martins Alves; Silvia Moreira Ayub Ferreira; Stéphanie Itala Rizk; Tiago Azevedo Costa Mattos; Vitor Barzilai; Wolney de Andrade Martins; Heinz-Peter Schultheiss
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.